Published July 2, 2019 | By Zachary Brennan The U.S. Food and Drug Administration (FDA) announced Monday night that it would remove the Risk Assessment and Mitigation Strategy (REMS) for Gilead's Truvada (emtricitabine/tenofovir disoproxil fumarate) and its four approved generics, which […]
FDA removes REMS for HIV drug Truvada and its generics Read More »
Recent research has uncovered the mechanism by which, in some HIV-infected patients, the viral load is not sufficiently reduced. Currently, antiretroviral medications have transformed HIV infection into a chronic condition for most patients by reducing the viral load to such low levels.
The cause of some patients' resistance to AIDS therapies has been discovered. Read More »
By EFE in Washington, July 29, 2019 - A team led by Steven Forsythe of the Avenir Health organization in the US evaluated the results between 1995 and 2015, according to an article published yesterday in the journal Health Affairs. Antiretroviral therapies for the human immunodeficiency virus (HIV) prevented 9.5 million deaths worldwide between 1995 and 2015.
Antiretroviral therapy prevented 9.5 million HIV deaths. Read More »
No one knew what killed Robert Rayford. The African American boy was only 15 years old when he showed up at St. Louis City Hospital in late 1968, but the medical team was baffled. An unexplained swelling in Rayford's genitals soon spread throughout his body. Chlamydia bacteria, usually
Fifty years of HIV: How close are we to a cure? Read More »
On June 27 and 28, 2019, the XXII National Conference on Infectious Diseases, "Strategies in the approach to infections in a country in crisis," was held in the Auditorium of the Hospital de Clínicas Caracas. This event also celebrated the 35th anniversary of the founding of the Venezuelan Society.
By: Elias El Hage On June 30th, Once Trece was present at the LGBTQ Pride march in Caracas. The demonstration seeks to raise awareness of the rights defended by this minority sector of society in Venezuela and around the world. The gathering was based at Generalísimo Francisco de Miranda Park, the location where Proyecto
Reviewed by Alina Shrourou, B.Sc. (Editor) June 29, 2019 Patients with HIV can suffer from a variety of illnesses. However, the prevalence of specific diseases can depend on geographic or demographic factors. A team of researchers from the University of Fort Hare in South Africa, led by Olufunso O. Sogbanmu, has studied the incidence of diabetes mellitus
Researchers highlight the need to intensify diabetes screening in older HIV patients. Read More »
Background: Doravirine is a novel non-nucleoside reverse transcriptase inhibitor with demonstrated efficacy in treatment-naïve adults with HIV-1. Methods: In this open-label, active-uncontrolled, non-inferiority trial, HIV-1-positive adults were virologically repressed for ≥6 months on two-nucleoside reverse transcriptase inhibitors plus a boosted protease inhibitor, boosted elvitegravir, or a non-nucleoside reverse transcriptase inhibitor.
Sex workers are 13 times more likely to be HIV-positive than the general population globally. But in Australia, where sex work is decriminalized, we have the same infection rate as the general population. This is evidence of the importance of the legal environment,” says Jules Kim, head of the Scarlet Alliance.
There is no end to AIDS without respecting human rights. Read More »
https://www.redaccionmedica.com/secciones/industria/-con-las-herramientas-actuales-podemos-cortar-la-tramsmision-del-vih–8325 Gilead ha organizado una reunión bajo el título de ‘¿Podemos controlar la epidemia del Sida? Cómo evitar nuevas infecciones’, coordinada por Josep Mallolas, jefe de la unidad VIH-SIDA del Hospital Clínic de Barcelona. Una de las conclusiones que se han extraído es que para implantar la estrategia de inicio rápido de tratamiento se requiere una atención clínica compartida basada en la coordinación
"With current tools we can stop HIV transmission" Read More »
